← Back to All Filings

Guardant Health Director Musa Tariq Sells 116 Shares Under Rule 10b5-1 Plan

Low SignificanceSeptember 17, 2026 at 6:57:58 PM EDT

Guardant Health, Inc.

$GH4CIK: 0001576280

Subscribe to track GH

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Guardant Health, Inc. ($GH) Form 4 Filing Update

Insider: Musa Tariq (Director) Transaction Date: September 16, 2026 Action: Sold 116 shares of Common Stock at $175.00/share ($20,300 total value) Post-Transaction Holdings: 11,449 shares Significance: Low (Small-volume sale executed under a pre-established Rule 10b5-1 trading plan following RSU vesting).

Comprehensive Analysis

Executive Summary

On September 17, 2026, Guardant Health, Inc. ($GH) filed a Form 4 reporting transactions by Director Musa Tariq. The report reflects the vesting of 249 Restricted Stock Units (RSUs) on September 15, 2026, followed by a sale of 116 shares of Common Stock on September 16, 2026, at $175.00 per share under a Rule 10b5-1 trading plan.

Transaction Details

  • Security: Common Stock
  • Acquisition (RSU Vesting): 249 shares acquired at $0.00 on September 15, 2026 (Code M).
  • Disposition (Sale): 116 shares sold at $175.00 per share on September 16, 2026 (Code S), generating gross proceeds of $20,300.
  • Ownership Post-Transaction: 11,449 shares directly held in Common Stock and 1,500 unvested RSUs.

Context and Analysis

  • Plan Trading: The transaction was executed pursuant to a Rule 10b5-1 trading arrangement indicated in the filing.
  • Significance: The transaction volume and total proceeds ($20,300) represent a routine, small-scale disposition typical of covering tax obligations or modest scheduled diversification post-vesting. Consequently, this transaction carries low informational signal for market participants.
Topics:#GuardantHealth#GH#InsiderSelling#Form4#SEC

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.